William A Jones Jr Biohaven Pharmaceutical Holding CO Ltd. (BHVN) insider trading activity

William A Jones Jr is CCO-Migraine & Common Disease of Biohaven Pharmaceutical Holding Co Ltd.. Currently has a direct ownership of 0 shares of BHVN, which is worth approximately $0. The most recent transaction as insider was on Oct 03, 2022, when has been sold 14,226 shares (Common Shares) at a price of $148.5 per share, resulting in proceeds of $2,112,561. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

WILLIAM A JONES Jr Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 03 2022	SELL Sale (or disposition) back to the issuer	$2,112,561 $148.5 p/Share	14,226 Reduced 100.0%	0 Common Shares
Jan 07 2022	SELL Payment of exercise price or tax liability	$210,187 $128.87 p/Share	1,631 Reduced 10.44%	13,999 Common Shares
Jan 07 2022	BUY Exercise of conversion of derivative security	-	3,750 Added 19.35%	15,630 Common Shares
Jan 06 2022	SELL Payment of exercise price or tax liability	$276,208 $123.86 p/Share	2,230 Reduced 15.8%	11,880 Common Shares
Jan 06 2022	BUY Exercise of conversion of derivative security	-	5,000 Added 26.16%	14,110 Common Shares
Nov 25 2021	SELL Payment of exercise price or tax liability	$150,793 $115.55 p/Share	1,305 Reduced 12.89%	8,822 Common Shares
Nov 25 2021	BUY Exercise of conversion of derivative security	-	3,000 Added 22.85%	10,127 Common Shares
Jan 06 2021	SELL Payment of exercise price or tax liability	$177,099 $83.38 p/Share	2,124 Reduced 22.96%	7,127 Common Shares
Jan 06 2021	BUY Exercise of conversion of derivative security	-	5,000 Added 35.09%	9,251 Common Shares
Nov 25 2020	SELL Payment of exercise price or tax liability	$112,224 $90.14 p/Share	1,245 Reduced 26.18%	3,510 Common Shares
Nov 25 2020	BUY Exercise of conversion of derivative security	-	3,000 Added 38.68%	4,755 Common Shares
Nov 02 2020	SELL Open market or private sale	$2,307,300 $76.91 p/Share	30,000 Reduced 94.47%	1,755 Common Shares
Nov 02 2020	BUY Exercise of conversion of derivative security	$1,521,600 $50.72 p/Share	30,000 Added 48.58%	31,755 Common Shares

Also insider at

DNAA

Social Capital Suvretta Holdings Corp. I

Director

APGE

Apogee Therapeutics, Inc.

Director

WAJ